Device maker offers lifetime guarantee on shoulder implant through Geisinger

The latest stories trending on MedCity News.

Editor's Pick

Top Story A Lifetime Guarantee on a Shoulder Implant? This Device Maker Is Offering It Through Geisinger Swiss Medtech Company Medacta teamed up with Geisinger to begin providing the world's first, lifetime guarantee on shoulder replacement surgeries. Sponsored Unlock New Revenue Streams from Healthcare Data - Without Sacrificing Privacy or Control Presented by datma datma.FED, a federated Real-World Data platform, enables health systems and labs to: Generate ongoing revenue from underutilized data assets Maintain full control over privacy and compliance Fund innovation and offset reimbursement challenges With minimal effort required, datma helps your organization monetize securely and sustainably.  Learn More Secure the Extreme Early Bird Rate Before it Ends This Friday, Dec 13th This week is your chance to grab your INVEST ticket at the lowest rate with the Extreme Early Bird discount. Take advantage of this limited-time offer and reserve your spot today.  Chicago May 20-21, top industry leaders, healthcare investors, innovators - what more could you ask for? Act Now to Save

Featured News

Cala Health Snags $50M for At-Home Tremor Relief Therapy Cala Health closed a $50 million funding round. The Silicon Valley-based company sells an FDA-cleared wearable device that temporarily relieves hand tremors in people with essential tremor and Parkinson's disease. GSK Multiple Myeloma Drug's DREAMM Comeback Continues With Phase 3 Data at ASH Results from the Phase 3 DREAMM-7 study show GSK drug Blenrep is helping multiple myeloma patients live longer compared to treatment with blockbuster Johnson & Johnson drug Darzalex. The data, presented Monday during the annual meeting of the American Society of Hematology, are part of a submission now under FDA review that could lead to Blenrep's return to the market. Soda Health Secures $50M to Grow Smart Benefits Platform Soda Health's $50 million Series B financing round was led by General Catalyst and included participation from former Humana CEO Bruce Broussard, Lightspeed Venture Partners, Define Ventures, Qiming Venture Partners USA and SVB Capital. How AI Can Close the Gap in Evidence-Based Care With evidence generated in minutes, the days of broad-based guidelines will be gone, as researchers and clinicians will have personalized evidence at their fingertips that can transform value-based care. A New Dawn in Patient Empowerment is Upon Us Wearables don't just tell us what a patient is doing — they can help us understand the context, the when and why. By linking behavior with context, we gain insights that self-reporting could never reveal.

Resources

MedCity Pivot Podcast: Chat With Shawn Gremminger About Employer-Led Healthcare How are employers tackling the current landscape of healthcare costs? We turned to Shawn Gremminger, CEO of the National Alliance of Healthcare Purchaser Coalitions, a group of regional coalitions representing self-insured employers large and small that cover roughly 40 million people. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe